Skip to main content

CAR T-Cell Therapy - Treatment of Various Hematological Malignancies

 

CAR T-cell (Chimeric Antigen Receptor T-cell) therapy is used predominantly in the treatment of various hematological malignancies (HMs), such as acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), lymphoma (diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma), and multiple myeloma (MM). HMs are blood cancers caused due to the uncontrolled growth of lymphoid and hematopoietic tissues (bone marrow). HMs are clinically and biologically heterogeneous disorders responsible for nearly 6.5% of all cancers across the globe, around 9.0% of cancers in the U.S. and Europe collectively. According to the estimates provided by Global Cancer Observatory (Globocan), an international agency for research on cancer, the total number of prevalent cases of hematologic malignancies in the world was 2,903,711 in 2018. The U.S. contributed around 15% of global prevalent cases of hematologic malignancies, and China contributed around 17% of total cases in 2018. As per the data published by the Leukemia and Lymphoma Society, in the U.S., approximately one person is diagnosed with hematologic cancer every three minutes. It is also estimated that by the end of 2020, the incidence of leukemia, lymphoma, or myeloma in the U.S. will reach 178,520 cases.

View BIS Report CAR T-Cell Therapy Market

About BIS Research

BIS Research, a premium market intelligence company offers in-depth insights and consulting to Fortune 500 companies. We are established and known for tracking the growth of deep technologies across key industry verticals and the subsequent challenges and opportunities associated with deep tech across markets, applications and products.

 

With more than 500 clients, over 7000 plus primary interviews and approximately 200 reports published in a year BIS Research has set an interesting growth trajectory for itself. We provide market estimations, emerging high-growth applications, technology analysis, highly segmented granular country-level market data, and other important market parameters that come in handy for our clients during strategic decision-making.

We publish a wide gamut of syndicated market studies across industry verticals. In addition, bespoke market studies is another area where BIS Research excels at along with consulting services.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale. Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices. BIS Research recently published a market intelligence report titled “ Global Neurostim...

Tilt Rotor Aircraft Market Analysis & Forecast by 2031

The tilt rotor aircraft has been constantly evolving over the years, facing numerous technical difficulties, and had several accidents due to its complex structure and design; the latest technologies such as vectored thrust and ducted fans are being used widely to tackle this problem. Several companies have been trying to enter the market to leverage the market need and increase their market share at a global level by making strategic partnerships with key players and raising funds from venture capitalists. Several private start-ups such as Lilium GmbH, Joby Aviation, Kitty Hawk, Overair have already developed prototypes or are still in the research and development phase to use the advantages of tilt rotor technology for civilian applications such as urban air mobility, cargo, and logistics transportation, and others. Read Report Overview: https://bisresearch.com/industry-report/tilt-rotor-aircraft-market.html The tilt rotor aircraft are initially used in the military and d...